135 related articles for article (PubMed ID: 26608289)
1. Detection of Circulating Tumor DNA in the Blood of Cancer Patients: An Important Tool in Cancer Chemoprevention.
Ulz P; Auer M; Heitzer E
Methods Mol Biol; 2016; 1379():45-68. PubMed ID: 26608289
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies.
Heitzer E; Ulz P; Geigl JB; Speicher MR
Mol Oncol; 2016 Mar; 10(3):494-502. PubMed ID: 26778171
[TBL] [Abstract][Full Text] [Related]
3. Dynamic sequencing of circulating tumor DNA: novel noninvasive cancer biomarker.
Lianos GD; Mangano A; Kouraklis G; Roukos DH
Biomark Med; 2014; 8(5):629-32. PubMed ID: 25123031
[No Abstract] [Full Text] [Related]
4. mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.
Belic J; Koch M; Ulz P; Auer M; Gerhalter T; Mohan S; Fischereder K; Petru E; Bauernhofer T; Geigl JB; Speicher MR; Heitzer E
Adv Exp Med Biol; 2016; 924():147-155. PubMed ID: 27753036
[TBL] [Abstract][Full Text] [Related]
5. Optimizing sparse sequencing of single cells for highly multiplex copy number profiling.
Baslan T; Kendall J; Ward B; Cox H; Leotta A; Rodgers L; Riggs M; D'Italia S; Sun G; Yong M; Miskimen K; Gilmore H; Saborowski M; Dimitrova N; Krasnitz A; Harris L; Wigler M; Hicks J
Genome Res; 2015 May; 25(5):714-24. PubMed ID: 25858951
[TBL] [Abstract][Full Text] [Related]
6. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments.
Sun K; Jiang P; Chan KC; Wong J; Cheng YK; Liang RH; Chan WK; Ma ES; Chan SL; Cheng SH; Chan RW; Tong YK; Ng SS; Wong RS; Hui DS; Leung TN; Leung TY; Lai PB; Chiu RW; Lo YM
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):E5503-12. PubMed ID: 26392541
[TBL] [Abstract][Full Text] [Related]
7. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing.
Leary RJ; Sausen M; Kinde I; Papadopoulos N; Carpten JD; Craig D; O'Shaughnessy J; Kinzler KW; Parmigiani G; Vogelstein B; Diaz LA; Velculescu VE
Sci Transl Med; 2012 Nov; 4(162):162ra154. PubMed ID: 23197571
[TBL] [Abstract][Full Text] [Related]
8. Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.
Azad AA; Volik SV; Wyatt AW; Haegert A; Le Bihan S; Bell RH; Anderson SA; McConeghy B; Shukin R; Bazov J; Youngren J; Paris P; Thomas G; Small EJ; Wang Y; Gleave ME; Collins CC; Chi KN
Clin Cancer Res; 2015 May; 21(10):2315-24. PubMed ID: 25712683
[TBL] [Abstract][Full Text] [Related]
9. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing.
Chan KC; Jiang P; Zheng YW; Liao GJ; Sun H; Wong J; Siu SS; Chan WC; Chan SL; Chan AT; Lai PB; Chiu RW; Lo YM
Clin Chem; 2013 Jan; 59(1):211-24. PubMed ID: 23065472
[TBL] [Abstract][Full Text] [Related]
10. Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.
Benesova L; Belsanova B; Suchanek S; Kopeckova M; Minarikova P; Lipska L; Levy M; Visokai V; Zavoral M; Minarik M
Anal Biochem; 2013 Feb; 433(2):227-34. PubMed ID: 22750103
[TBL] [Abstract][Full Text] [Related]
11. A novel framework for analyzing somatic copy number aberrations and tumor subclones for paired heterogeneous tumor samples.
Xia H; Li A; Yu Z; Liu X; Feng H
Biomed Mater Eng; 2015; 26 Suppl 1():S1845-53. PubMed ID: 26405956
[TBL] [Abstract][Full Text] [Related]
12. Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities.
Esposito A; Bardelli A; Criscitiello C; Colombo N; Gelao L; Fumagalli L; Minchella I; Locatelli M; Goldhirsch A; Curigliano G
Cancer Treat Rev; 2014 Jun; 40(5):648-55. PubMed ID: 24184333
[TBL] [Abstract][Full Text] [Related]
13. Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications.
Lo YM; Chiu RW
J Pathol; 2011 Nov; 225(3):318-23. PubMed ID: 21984122
[TBL] [Abstract][Full Text] [Related]
14. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples.
Ishii H; Azuma K; Sakai K; Kawahara A; Yamada K; Tokito T; Okamoto I; Nishio K; Hoshino T
Oncotarget; 2015 Oct; 6(31):30850-8. PubMed ID: 26334838
[TBL] [Abstract][Full Text] [Related]
15. Exome sequence read depth methods for identifying copy number changes.
Kadalayil L; Rafiq S; Rose-Zerilli MJ; Pengelly RJ; Parker H; Oscier D; Strefford JC; Tapper WJ; Gibson J; Ennis S; Collins A
Brief Bioinform; 2015 May; 16(3):380-92. PubMed ID: 25169955
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.
Alkodsi A; Louhimo R; Hautaniemi S
Brief Bioinform; 2015 Mar; 16(2):242-54. PubMed ID: 24599115
[TBL] [Abstract][Full Text] [Related]
17. Whole cancer genome sequencing by next-generation methods.
Ross JS; Cronin M
Am J Clin Pathol; 2011 Oct; 136(4):527-39. PubMed ID: 21917674
[TBL] [Abstract][Full Text] [Related]
18. eTumorType, An Algorithm of Discriminating Cancer Types for Circulating Tumor Cells or Cell-free DNAs in Blood.
Zou J; Wang E
Genomics Proteomics Bioinformatics; 2017 Apr; 15(2):130-140. PubMed ID: 28389380
[TBL] [Abstract][Full Text] [Related]
19. Circulating cell-free DNA in cancer.
Pinzani P; Salvianti F; Orlando C; Pazzagli M
Methods Mol Biol; 2014; 1160():133-45. PubMed ID: 24740228
[TBL] [Abstract][Full Text] [Related]
20. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
